Novanta Inc. (NOVT) Financials
NOVT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 1.2 billion | 552.6 million |
2023-09-30 | 1.2 billion | 549.4 million |
2023-06-30 | 1.2 billion | 606.7 million |
2023-03-31 | 1.2 billion | 627.8 million |
NOVT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 31.3 million | 7.2 million |
2023-09-30 | 37.8 million | 6.0 million |
2023-06-30 | 22.9 million | 5.9 million |
2023-03-31 | 6.6 million | 6.5 million |
NOVT Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 12.5 million |
2023-09-30 | 21.2 million |
2023-06-30 | 20.9 million |
2023-03-31 | 18.3 million |
NOVT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 105.1 million | - | 50.2 million |
2023-09-30 | 76.0 million | - | 51.5 million |
2023-06-30 | 91.3 million | - | 53.6 million |
2023-03-31 | 82.7 million | 418.5 million | 52.4 million |
NOVT Shares Outstanding
NOVT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 6.0 million | 23.5 million | 41.7 million | - |
2023-09-30 | 6.8 million | 22.0 million | 39.6 million | - |
2023-06-30 | 3.3 million | 23.4 million | 42.2 million | - |
2023-03-31 | 3.6 million | 22.8 million | 40.9 million | - |
NOVT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 211.6 million | 117.7 million |
2023-09-30 | 221.5 million | 119.9 million |
2023-06-30 | 229.5 million | 125.3 million |
2023-03-31 | 219.1 million | 121.5 million |
NOVT
Price: $159.89
52 week price:
Earnings Per Share: 2.02 USD
P/E Ratio: 73.70
Exchange: NMS
Sector: Technology
Industry: Scientific & Technical Instruments
Volume: 73700
Ebitda: 21.1 millionMarket Capitalization: 6.1 billion